<DOC>
	<DOCNO>NCT02472249</DOCNO>
	<brief_summary>Dr Rajan investigate new method improve local treatment liver cancer . There evidence drug , norepinephrine ( NE ) , ability shrink normal liver blood vessel , leave tumor vessel wide open . In patient primary liver cancer , NE inject directly artery nourishes liver tumor . Real time blood flow measure use advanced CT scanner demonstrate NE effect blood vessel . If Dr Rajan 's hypothesis confirm , drug great potential benefit patient local delivery chemotherapy liver artery , divert away normal liver towards tumor , result less complication improve tumor kill .</brief_summary>
	<brief_title>Pharmacological Manipulation Intrahepatic Arterial Blood Flow HCC</brief_title>
	<detailed_description>This study aim evaluate blood flow modification liver follow injection norepinephrine hepatic artery . These blood flow variation never dynamically evaluate . If indeed blood flow modulation liver favorable , use norepinephrine prior localize chemotherapy great potential enhance treatment diminish side effect . Patients hepatocellular carcinoma , primary liver cancer , select study . Included patient trans-arterial chemoembolization ( TACE ) procedure schedule treatment cancer . During procedure , bring advanced CT-scanner . CT perfusion imaging perform prior , injection study drug liver artery . Patient 's treatment complete . Perfusion color map illustrate blood flow . Perfusion value correlate see drug modulates blood flow tumor normal liver .</detailed_description>
	<mesh_term>Carcinoma</mesh_term>
	<mesh_term>Carcinoma , Hepatocellular</mesh_term>
	<mesh_term>Norepinephrine</mesh_term>
	<criteria>Biopsy proven HCC &lt; confident diagnosis HCC multiphasic CT MRI Selection criterion chemoembolization must meet , include adequate coagulation profile serum creatinine , patent portal vein , severe contrast allergy , cirrhosis Child A B . 5 less untreated nodular hepatic tumor within lobe undergo chemoembolization . Larger nodule must equal 3 cm . Patient must able provide write , informed consent . Symptoms history ischemic cardiac disease arrhythmia Uncontrolled hypertension Pregnancy desire get pregnant Severe COPD , FEVS low 30 % Prior document hypersensitivity norepinephrine Patients receive MAO inhibitor , antidepressant triptyline imipramine type</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>November 2016</verification_date>
	<keyword>TACE</keyword>
	<keyword>CT perfusion</keyword>
	<keyword>Liver blood flow</keyword>
</DOC>